Vineet Arora to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Vineet Arora has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.023
-
Shift from surrogate end point to outcome trials: implications for cardiovascular safety assessment in development programs for antidiabetic drugs. Clin Pharmacol Ther. 2012 Mar; 91(3):514-20.
Score: 0.023